A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
for Urinary Bladder Neoplasms
19 locations incl. Bakersfield
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06833073·Phase 2·Recruiting·Listed Feb 2025